IHC staining with proliferation marker Ki-67 showed that fewer cells were Ki-67-positive in MAP4K1-KD tumors relative to NC tumors (Fig 4E), indicating that MAP4K1 promotes glioma cell proliferation in vivo. The gene discussed is MAP4K1; the disease is central nervous system cancer.